MetLife Investment Product — Investment performance decreased by 239.4% to -75700000000.0% in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 350.6%, from -16800000000.0% to -75700000000.0%. Over 2 years (FY 2021 to FY 2025), Investment Product — Investment performance shows a downward trend with a -17.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher performance indicates effective asset management and contributes to higher profitability and product competitiveness.
This metric measures the net investment results, including interest, dividends, and capital gains/losses, generated by t...
Standard metric for evaluating the investment arm of any insurance or financial services firm.
met_segment_investment_product_investment_performance| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 155,650,000,000% | 155,650,000,000% | 155,650,000,000% | -407,800,000,000% | -616,500,000,000% | -230,700,000,000% | 222,500,000,000% | 115,600,000,000% | -179,800,000,000% | 375,200,000,000% | 171,300,000,000% | 16,400,000,000% | 237,500,000,000% | -16,800,000,000% | 212,900,000,000% | 169,400,000,000% | 54,300,000,000% | -75,700,000,000% |
| QoQ Change | — | +0.0% | +0.0% | -362.0% | -51.2% | +62.6% | +196.4% | -48.0% | -255.5% | +308.7% | -54.3% | -90.4% | >999% | -107.1% | >999% | -20.4% | -67.9% | -239.4% |
| YoY Change | — | — | — | — | -496.1% | -248.2% | +154.6% | +118.8% | +22.1% | — | -23.0% | -85.8% | +232.1% | -109.8% | >999% | -28.7% | — | -350.6% |